版本:
中国

BRIEF-Amgen, Harvard Pilgrim agree to contract for repatha

May 2 Amgen Inc:

* Amgen and Harvard Pilgrim agree to first cardiovascular outcomes-based refund contract for repatha (evolocumab)

* Amgen - contract provides Harvard Pilgrim with a rebate for cost of repatha for an eligible patient who has a heart attack or stroke while on repatha Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐